Vezeeta
PrivateLast Round
Growth Equity
Oct 11, 2022
Est. Valuation
$32M
Total Funding Raised
$64M
Company Overview
Vezeeta operates in Healthcare & Life Sciences and is based in Cairo. Its latest recorded funding round was a Growth Equity round in October 2022.
Vezeeta is a healthcare technology company that provides a digital platform for patients to search, compare, and book medical appointments, while offering practice management software for healthcare providers.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, E-commerce, Subscription Commerce
Business Model
B2C
Customer Profile
Marketplace Commission, Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vezeeta Comparables
Compare Vezeeta with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Altibbi | 82% | |
| Okadoc | 78% | |
| Mawidy | 76% |
For institutional investors. Book with your work email.
Vezeeta Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Oct 11, 2022 | ||||
| Series D | Feb 11, 2020 | ||||
| Series C Extension | Dec 7, 2018 | ||||
| Series C | Sep 19, 2018 | ||||
| Series B Extension | May 15, 2017 | ||||
Series B | Sep 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vezeeta Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| International Finance Corporation | Series C |
| VNV Global | Growth Equity, Series B Extension, Series C, Series B, Series D |
| BECO Capital | Series C, Series D, Series B Extension, Series B |
| Accelerator Technology Holdings | Series C |
| Gulf Capital | Growth Equity, Series D |
| STV | Series D, Series C |
| CE-Ventures | Series C, Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Served over 10 million patients across 6 countries.
- Jan 1, 2025
Job posting reveals 'Shamel plans' for health benefits and payments.
For institutional investors. Book with your work email.
Vezeeta Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vezeeta's valuation, stock price, and market status.
Is Vezeeta a public or private company?
Vezeeta is a private company.
What is the current stock price of Vezeeta?
Vezeeta is a private company, so its shares have no public market price. Caplight tracks Vezeeta's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vezeeta worth (valuation)?
Vezeeta's valuation is estimated at $32.0M based on funding round data.
Can I buy Vezeeta stock?
Vezeeta shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vezeeta's last funding round?
Vezeeta's most recent funding round was Growth Equity on October 11, 2022.
Who are the main investors in Vezeeta?
Key investors in Vezeeta include BECO Capital, Gulf Capital, STV, Silicon Badia.
Will Vezeeta IPO soon?
No public IPO plans have been announced for Vezeeta.
How can I track Vezeeta secondary market activity?
Caplight tracks bids, offers, and trades in Vezeeta's shares on secondary markets.